美股异动 | LB Pharmaceuticals(LBRX.US)登陆美股市场 开盘涨超20%

智通财经
Sep 12
【美股异动 | LB Pharmaceuticals(LBRX.US)登陆美股市场 开盘涨超20%】智通财经APP获悉,周四,致力于开发神经精神疾病药物的生物科技公司LB Pharmaceuticals(LBRX.US)登陆美股市场,开盘股价上涨超20%,报18.12美元。IPO价格为15美元。LB Pharmaceuticals的领先候选药物LB-102是一种准备进入III期临床试验的口服小分子药物,用于治疗急性精神分裂症,这是一种以幻觉和妄想为特征的慢性疾病,影响着大约1%的美国人口。在359名患者参与的2期临床试验中,该药物在第4周时达到了主要终点。LB Pharmaceuticals预计将于2026年第一季度开始III期临床试验。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10